Design and characterisation of doxorubicin-releasing chitosan microspheres for anti-cancer chemoembolisation

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Rel 2004; 100: 5–28
   PubMed Web of Science ®Google Scholar
• Anal AK, Stevens WF, Remuñán-López C. Ionotropic cross-linked chitosan micospheres for controlled release of ampicillin. Int J Pharm 2006; 312: 166–73
   PubMed Web of Science ®Google Scholar
• Beijnen JH, Van Der Houwen OAGJ, Underberg WJM. Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int J Pharm 1986; 32: 123–31
   Web of Science ®Google Scholar
• Bhumkar DR, Pokharkar VB. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note. AAPS PharmSciTech 2006; 7: E1–7
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sa’nchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001; 224: 159–68
   PubMed Web of Science ®Google Scholar
• Denkbas EB, Odabasi M. Chitosan microspheres and sponges: Preparation and characterization. J Appl Polym Sci 2000; 76: 1637–43
   Web of Science ®Google Scholar
• Dion JE, Rankin RN, Vinuela F, Fox AJ, Wallace AC, Mervart M. Dextran microsphere embolization: Experimental and clinical experience with radiologic–pathologic correlation – Work in progress. Radiology 1986; 160: 717–21
   PubMed Web of Science ®Google Scholar
• Du WL, Niu SS, Xu YL, Xu ZR, Fan CL. Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions. Carbohydr Polym 2009; 75: 385–9
   Web of Science ®Google Scholar
• Fan H, Dash A. Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int J Pharm 2001; 213: 103–16
   PubMed Web of Science ®Google Scholar
• Fang YY, Wang LJ, Li D, Li BZ, Bhandari B, Chen XD, Mao ZH. Preparation of crosslinked starch microspheres and their drug loading and releasing properties. Carbohydr Polym 2008; 74: 379–84
   Web of Science ®Google Scholar
• Fujimoto S, Miyazaki M, Endoh F, Takahashi O, Okui K, Morimoto Y. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. Cancer 1985; 56: 2404–10
   Google Scholar
• Grandfils C, Flandroy P, Jerome R. Control of the biodegradation rate of poly (DL-lactide) microparticles intended as chemoembolization materials. J Control Rel 1996; 38: 109–22
   Web of Science ®Google Scholar
• Ishii H, Minegishi M, Lavitpichayawong B, Mitani T. Synthesis of chitosan–amino acid conjugates and their use in heavy metal uptake. Int J Biol Macromol 1995; 17: 21–3
   PubMed Web of Science ®Google Scholar
• Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progesterone-loaded chitosan microspheres: A long-acting controlled delivery system. J Control Rel 1998; 52: 17–24
   PubMed Web of Science ®Google Scholar
• Janes KA, Fresneau MP, Marazuela A, Fabra A, Jose’Alonsoa M. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Rel 2001; 73: 255–67
   PubMed Web of Science ®Google Scholar
• Kang MJ, Park JM, Choi WS, Lee J, Kwak BK, Lee J. Highly spherical and deformable chitosan microspheres for arterial embolization. Chem Pharm Bull 2010; 58: 288–92
   PubMed Web of Science ®Google Scholar
• Kim JS, Kwak BK, Shim HJ, Lee YC, Baik HW, Lee MJ, Han S-M, Son SH, Kim YB, Tkura S, et al. Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma. J Microencap 2007; 24: 408–19
   PubMed Web of Science ®Google Scholar
• Laurent A, Beaujeux R, Wassef M, Rufenacht D, Boschetti E, Merland JJ. Trisacrylgelatin microspheres for therapeutic embolization I: Development and in vitro evaluation. Am J Neuroradiol 1996; 17: 533–40
   PubMed Web of Science ®Google Scholar
• Lee K-H, Liapi EA, Cornell C, Reb P, Buijs M, Vossen JA, Ventura VP, Geschwind J-FH. Doxorubicin-loaded QuadraSphere microspheres: Plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol 2010; 33: 576–82
   PubMed Web of Science ®Google Scholar
• Leeper DB, Engin K, Thistlethwaite AJ, Hitchon HD, Dover JD, Li DJ, Tupchong L. Human tumor extracellular pH as a function of blood glucose concentration. Int J Radiat Oncol Biol Phys 1994; 28: 935–43
   PubMed Web of Science ®Google Scholar
• Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL, Leppard SW, Wolfenden LC, Palmer RR, Stratford PW. DC bead: In vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006; 17: 335–42
   PubMed Web of Science ®Google Scholar
• Mi FL, Tan YC, Liang HC, Huang RN, Sung HW. In vitro evaluation of a chitosan membrane cross-linked with genipin. J Biomater Sci Polym Ed 2001; 12: 835–50
   PubMed Web of Science ®Google Scholar
• Monteiro OA, Airoldi C. Some studies of crosslinking chitosan–glutaraldehyde interaction in a homogeneous system. Int J Biol Macromol 1999; 26: 119–28
   PubMed Web of Science ®Google Scholar
• Päuser S, Zschunke A, Keller K. Interaction between paramagnetic metal complexes and intracellular water of single cells. J Magn Reson Imag 1996; 6: 250–4
   PubMed Web of Science ®Google Scholar
• Rao KSVK, Naidu BVK, Subha MCS, Sairam M, Aminabhavi M. Novel chitosan-based pH-sensitive interpenetrating network microgels for the controlled release of cefadroxil. Carbohydr Polym 2006; 66: 333–44
   Web of Science ®Google Scholar
• Ravivarapu HB, Lee H, DeLuca PP. Enhancing initial release of peptide frompoly(D, L-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm Dev Tech 2000; 5: 287–96
   PubMed Web of Science ®Google Scholar
• Ren D, Yi H, Wang W, Ma X. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydr Res 2005; 340: 2403–10
   PubMed Web of Science ®Google Scholar
• Sankar C, Mishra B. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm 2003; 53: 101–10
   PubMedGoogle Scholar
• Scheithauer W, Zielinksi C, Ludwig H. Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment. Breast Cancer Res Treat 1985; 6: 89–93
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled drug delivery. Int J Pharm 2000; 201: 51–8
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencap 2001; 18: 237–45
   PubMed Web of Science ®Google Scholar
• Stuart K. Chemoembolization in the management of liver tumors. Oncologist 2003; 8: 425–37
   PubMed Web of Science ®Google Scholar
• Tsai ML, Bai SW, Chen RH. Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan–sodium tripolyphosphate nanoparticles. Carbohydr Polym 2008; 71: 448–57
   Web of Science ®Google Scholar
• Urva SR, Shin BS, Yang VC, Balthasar JP. Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues. J Chrom B 2009; 877: 837–41
   PubMed Web of Science ®Google Scholar
• Van Es RJJ, Franssen O, Dullens HF, Bernsen MR, Bosman F, Hennink WE, Slootweg PJ. The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres. Lab Anim 1999; 33: 175–84
   PubMed Web of Science ®Google Scholar
• Wang C, Liu J, Pan W, Wang X, Gao Q, Hou S. Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy—In vitro and in vivo studies. Int J Pharm 2008; 351: 219–26
   PubMed Web of Science ®Google Scholar
• Wang LY, Gu YH, Su ZG, Ma GH. Preparation and improvement of release behavior of chitosan microspheres containing insulin. Int J Pharm 2006; 311: 187–95
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003; 250: 215–26
   PubMed Web of Science ®Google Scholar